Recent news on Ketotifen

The Eyes Have It!  -  Apr 28, 2007
About - News & Issues,Zaditor® (ketotifen), indicated for the treatment of allergic conjunctivitis, is now available OTC. This medication, unlike other OTC eye drops,

Dropping In on Eye Allergy Relief  -  Apr 30, 2007
FOX NewsAnother type of mast cell stabilizer, ketotifen eye drops, sold under brand names Zaditor and Alaway, have recently been approved by the FDA and are now

The Time of the (Allergy) Season  -  Mar 29, 2007
FOX NewsThe Food and Drug Administration has just approved ketotifen eye drops for over-the-counter use. Until now, ketotifen eye drops were only available with a

Ankur Drugs & Pharma signs Term Sheet with "Labtech" of GMBH ...  -  Mar 1, 2007
Equity Bulls,...line) Viz Rapid film for Ondansetrone, Donepezil- Hcl, Ketotifen Fumarate, Baclofe, Rivastigmine, Sildenafil Citrate, Glimepiride and Olanzapine.

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),Under the transaction, Bausch & Lomb will take control of Alaway (ketotifen fumarate 0.025%), the OTC equivalent to Zaditor (ketotifen fumarate 0.025%,

Inspire to Present Data at 2007 American Academy of Allergy ...  -  Feb 23, 2007
PharmaLive.com (press release),...cetirizine, desloratadine, fexofenadine, ketotifen and olopatadine, compared to bilastine and epinastine, related compounds in Inspire's portfolio.

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),...allergy franchise, including Alaway (ketotifen fumarate ophthalmic solution 0.025%), which was recently approved by the US Food and Drug Administration.

OTC Ketotifen Fumarate Ophthalmic Solution Approved  -  Dec 5, 2006
Facts and Comparisons,The FDA has approved Alimera Sciences’ NDA of an Rx-to-OTC switch for ketotifen fumarate 0.025% ophthalmic solution (Alaway), a multiple-action antiallergic

Alimera Sciences Receives FDA Approval To Market Alaway(TM) OTC ...  -  Dec 6, 2006
Medical News Today (press release),...after completing a successful clinical study that showed it to be bioequivalent to Novartis' Zaditor(R) (ketotifen fumarate ophthalmic solution 0.025%).

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),...allergy franchise, including Alaway (ketotifen fumarate ophthalmic solution 0.025%), which was recently approved by the US Food and Drug Administration.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional